Feasibility of metronomic oral cyclophosphamide plus prednisolone in elderly patients with inoperable or metastatic soft tissue sarcoma

European Journal of Cancer

Volumn 47, Issue 4, 2011, Pages 515-519

  Mir, Olivier ^a   Domont, Julien ^a   Cioffi, Angela ^a   Bonvalot, Sylvie ^a   Boulet, Bérénice ^a   Le Pechoux, Cécile ^a   Terrier, Philippe ^a   Spielmann, Marc ^a   Le Cesne, Axel ^a  

^a INSTITUT GUSTAVE ROUSSY   (France)

Author keywords

Cyclophosphamide; Elderly; Prednisolone; Radiation induced sarcoma; Sarcoma; Soft tissue sarcoma

Indexed keywords

CYCLOPHOSPHAMIDE; ETOPOSIDE; PACLITAXEL; PREDNISOLONE;

AGED; ANEMIA; ANGIOSARCOMA; ANOREXIA; ARTICLE; ASTHENIA; CLINICAL ARTICLE; DRUG DOSE REDUCTION; DRUG SAFETY; FEASIBILITY STUDY; FEBRILE NEUTROPENIA; FEMALE; HUMAN; INOPERABLE CANCER; LEIOMYOSARCOMA; LIPOSARCOMA; LYMPHOCYTOPENIA; MALE; METASTASIS; MULTIPLE CYCLE TREATMENT; NAUSEA; NEUTROPENIA; OPPORTUNISTIC INFECTION; PRIORITY JOURNAL; PROGRESSION FREE SURVIVAL; SARCOMA; SOFT TISSUE SARCOMA; THROMBOCYTOPENIA; TREATMENT RESPONSE; VOMITING;

ADMINISTRATION, ORAL; AGED; AGED, 80 AND OVER; ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS; CYCLOPHOSPHAMIDE; DISEASE-FREE SURVIVAL; FEASIBILITY STUDIES; FEMALE; HUMANS; MALE; PREDNISOLONE; SARCOMA; SOFT TISSUE NEOPLASMS; TOMOGRAPHY, X-RAY COMPUTED; TREATMENT OUTCOME;

EID: 79851508021     PISSN: 09598049     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ejca.2010.11.025     Document Type: Article

References (22)

1. G. Lahat, A. Lazar, and D. Lev Sarcoma epidemiology and etiology: potential environmental and genetic factors Surg Clin North Am 88 3 2008 451 481 v (Pubitemid 351734513)
2. P.H. Nijhuis, M. Schaapveld, and R. Otter Epidemiological aspects of soft tissue sarcomas (STS) - consequences for the design of clinical STS trials Eur J Cancer 35 12 1999 1705 1710 (Pubitemid 30050644)
3. G. Lahat, A.R. Dhuka, and S. Lahat Complete soft tissue sarcoma resection is a viable treatment option for select elderly patients Ann Surg Oncol 16 9 2009 2579 2586
4. P.G. Casali, L. Jost, S. Sleijfer, J. Verweij, and J.Y. Blay Soft tissue sarcomas: ESMO clinical recommendations for diagnosis, treatment and follow-up Ann Oncol 20 Suppl 4 2009 132 136
5. A.L. Ferreira, L.S. Matsubara, and B.B. Matsubara Anthracycline-induced cardiotoxicity Cardiovasc Hematol Agents Med Chem 6 4 2008 278 281
6. O. Mir, J. Alexandre, and S. Ropert Combination of gemcitabine and oxaliplatin in urothelial cancer patients with severe renal or cardiac comorbidities Anticancer Drugs 16 9 2005 1017 1021 (Pubitemid 41416093)
7. F.A. Hayes, E.I. Thompson, and W.H. Meyer Therapy for localized Ewing's sarcoma of bone J Clin Oncol 7 2 1989 208 213 (Pubitemid 19048454)
8. U. Emmenegger, S. Man, and Y. Shaked A comparative analysis of low-dose metronomic cyclophosphamide reveals absent or low-grade toxicity on tissues highly sensitive to the toxic effects of maximum tolerated dose regimens Cancer Res 64 11 2004 3994 4000 (Pubitemid 38697315)
9. M. Colleoni, A. Rocca, and M.T. Sandri Low-dose oral methotrexate and cyclophosphamide in metastatic breast cancer: antitumor activity and correlation with vascular endothelial growth factor levels Ann Oncol 13 1 2002 73 80 (Pubitemid 34436728)
10. R. Lord, S. Nair, and A. Schache Low dose metronomic oral cyclophosphamide for hormone resistant prostate cancer: a phase II study J Urol 177 6 2007 2136 2140 discussion 2140 (Pubitemid 46726410)
11. E. Borne, E. Desmedt, and A. Duhamel Oral metronomic cyclophosphamide in elderly with metastatic melanoma Invest New Drugs 28 5 2009 684 689
12. A.B. Miller, B. Hoogstraten, M. Staquet, and A. Winkler Reporting results of cancer treatment Cancer 47 1 1981 207 214 (Pubitemid 11167383)
13. M. Trojani, G. Contesso, and J.M. Coindre Soft-tissue sarcomas of adults; study of pathological prognostic variables and definition of a histopathological grading system Int J Cancer 33 1 1984 37 42 (Pubitemid 14223231)
14. W.G. Cahan, and H.Q. Woodard Sarcoma arising in irradiated bone; report of 11 cases Cancer 1 1 1948 3 29
15. L.F. Hutchins, J.M. Unger, J.J. Crowley, C.A. Coltman Jr., and K.S. Albain Underrepresentation of patients 65 years of age or older in cancer-treatment trials N Engl J Med 341 27 1999 2061 2067 (Pubitemid 30035956)
16. R.F. Miller, J. Le Noury, E.L. Corbett, J.M. Felton, and K.M. De Cock Pneumocystis carinii infection: current treatment and prevention J Antimicrob Chemother 37 Suppl. B 1996 33 53 (Pubitemid 26283307)
17. T. Warren, J. Harris, and C.A. Brennan Efficacy and safety of valacyclovir for the suppression and episodic treatment of herpes simplex virus in patients with HIV Clin Infect Dis 39 Suppl 5 2004 S258 S266
18. A. Italiano, M. Toulmonde, and B. Lortal 'Metronomic' chemotherapy in advanced soft tissue sarcomas Cancer Chemother Pharmacol 66 1 2010 197 202
19. T. Browder, C.E. Butterfield, and B.M. Kraling Antiangiogenic scheduling of chemotherapy improves efficacy against experimental drug-resistant cancer Cancer Res 60 7 2000 1878 1886 (Pubitemid 30207647)
20. F. Ghiringhelli, C. Menard, and P.E. Puig Metronomic cyclophosphamide regimen selectively depletes CD4+CD25+ regulatory T cells and restores T and NK effector functions in end stage cancer patients Cancer Immunol Immunother 56 5 2007 641 648 (Pubitemid 46348738)
21. S.R. Patel Radiation-induced sarcoma Curr Treat Options Oncol 1 3 2000 258 261
22. W.M. Mendenhall, D.J. Indelicato, and M.T. Scarborough The management of adult soft tissue sarcomas Am J Clin Oncol 32 4 2009 436 442